Neoadjuvant Chemotherapy and Biological Treatment for Patients With Locally Advanced Colon Cancer.
Phase of Trial: Phase II
Latest Information Update: 20 May 2015
At a glance
- Drugs Panitumumab (Primary) ; Capecitabine; Oxaliplatin
- Indications Colon cancer
- Focus Therapeutic Use
- 20 May 2015 Status changed from active no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Jun 2013 Planned end date changed from 1 Jul 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 22 Apr 2010 New trial record